Denial
发表于 2025-3-21 17:19:26
书目名称Cancer Therapy影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0221213<br><br> <br><br>书目名称Cancer Therapy影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0221213<br><br> <br><br>书目名称Cancer Therapy网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0221213<br><br> <br><br>书目名称Cancer Therapy网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0221213<br><br> <br><br>书目名称Cancer Therapy被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0221213<br><br> <br><br>书目名称Cancer Therapy被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0221213<br><br> <br><br>书目名称Cancer Therapy年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0221213<br><br> <br><br>书目名称Cancer Therapy年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0221213<br><br> <br><br>书目名称Cancer Therapy读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0221213<br><br> <br><br>书目名称Cancer Therapy读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0221213<br><br> <br><br>
无聊点好
发表于 2025-3-21 22:17:20
http://reply.papertrans.cn/23/2213/221213/221213_2.png
larder
发表于 2025-3-22 02:13:26
https://doi.org/10.1007/978-981-19-5570-9lonal antibodies has rapidly led to clinical investigations. Experience with monoclonal antibodies in the treatment of patients with melanoma is limited because only small groups of patients have been treated so far. According to these studies, treatment with ganglioside antibodies appears most promising.
NOMAD
发表于 2025-3-22 05:04:32
http://reply.papertrans.cn/23/2213/221213/221213_4.png
Munificent
发表于 2025-3-22 11:03:17
http://reply.papertrans.cn/23/2213/221213/221213_5.png
Figate
发表于 2025-3-22 16:41:33
Mab 17-1A Used for Therapy of Patients with Metastatic Colorectal Carcinomasially on fetal cells. On normal mature cells, TAA might be detected only by highly sensitive techniques or after manipulation of the cell membrane. On malignant cells, TAA are often re-expressed in high concentrations. Such antigens can be exploited not only for diagnostic purposes, but also as targets for immunotherapy.
Figate
发表于 2025-3-22 17:07:38
Immunotherapy of Malignant Melanomaslonal antibodies has rapidly led to clinical investigations. Experience with monoclonal antibodies in the treatment of patients with melanoma is limited because only small groups of patients have been treated so far. According to these studies, treatment with ganglioside antibodies appears most promising.
坦白
发表于 2025-3-22 21:34:30
The Role of Interferon in the Management of Patients with Hairy Cell Leukemia and Multiple Myeloma of cancer, particularly since in 1981 highly purified material produced by recombinant DNA technology has become available in addition to natural IFNs . So far, the most impressive clinical results have been achieved in hematologic disorders, especially in hairy cell leukemia .
terazosin
发表于 2025-3-23 02:08:21
http://reply.papertrans.cn/23/2213/221213/221213_9.png
crease
发表于 2025-3-23 06:47:33
http://reply.papertrans.cn/23/2213/221213/221213_10.png